Literature DB >> 30449682

Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells.

Martina Bajzikova1, Jaromira Kovarova2, Ana R Coelho3, Stepana Boukalova4, Sehyun Oh5, Katerina Rohlenova4, David Svec4, Sona Hubackova4, Berwini Endaya6, Kristyna Judasova4, Ayenachew Bezawork-Geleta6, Katarina Kluckova4, Laurent Chatre7, Renata Zobalova4, Anna Novakova4, Katerina Vanova4, Zuzana Ezrova1, Ghassan J Maghzal8, Silvia Magalhaes Novais1, Marie Olsinova9, Linda Krobova4, Yong Jin An5, Eliska Davidova1, Zuzana Nahacka4, Margarita Sobol10, Teresa Cunha-Oliveira11, Cristian Sandoval-Acuña4, Hynek Strnad10, Tongchuan Zhang12, Thanh Huynh13, Teresa L Serafim11, Pavel Hozak10, Vilma A Sardao11, Werner J H Koopman14, Miria Ricchetti7, Paulo J Oliveira11, Frantisek Kolar15, Mikael Kubista4, Jaroslav Truksa4, Katerina Dvorakova-Hortova1, Karel Pacak13, Robert Gurlich16, Roland Stocker8, Yaoqi Zhou12, Michael V Berridge17, Sunghyouk Park18, Lanfeng Dong19, Jakub Rohlena20, Jiri Neuzil21.   

Abstract

Cancer cells without mitochondrial DNA (mtDNA) do not form tumors unless they reconstitute oxidative phosphorylation (OXPHOS) by mitochondria acquired from host stroma. To understand why functional respiration is crucial for tumorigenesis, we used time-resolved analysis of tumor formation by mtDNA-depleted cells and genetic manipulations of OXPHOS. We show that pyrimidine biosynthesis dependent on respiration-linked dihydroorotate dehydrogenase (DHODH) is required to overcome cell-cycle arrest, while mitochondrial ATP generation is dispensable for tumorigenesis. Latent DHODH in mtDNA-deficient cells is fully activated with restoration of complex III/IV activity and coenzyme Q redox-cycling after mitochondrial transfer, or by introduction of an alternative oxidase. Further, deletion of DHODH interferes with tumor formation in cells with fully functional OXPHOS, while disruption of mitochondrial ATP synthase has little effect. Our results show that DHODH-driven pyrimidine biosynthesis is an essential pathway linking respiration to tumorigenesis, pointing to inhibitors of DHODH as potential anti-cancer agents.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  OXPHOS; cancer; coenzyme Q; dihydroorotate dehydrogenase; mitochondria; pyrimidine biosynthesis; respiration

Mesh:

Substances:

Year:  2018        PMID: 30449682      PMCID: PMC7484595          DOI: 10.1016/j.cmet.2018.10.014

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  93 in total

1.  Cell cycle-dependent regulation of pyrimidine biosynthesis.

Authors:  Frederic D Sigoillot; J Andrew Berkowski; Severine M Sigoillot; Damian H Kotsis; Hedeel I Guy
Journal:  J Biol Chem       Date:  2002-11-15       Impact factor: 5.157

2.  The CoQH2/CoQ Ratio Serves as a Sensor of Respiratory Chain Efficiency.

Authors:  Adela Guarás; Ester Perales-Clemente; Enrique Calvo; Rebeca Acín-Pérez; Marta Loureiro-Lopez; Claire Pujol; Isabel Martínez-Carrascoso; Estefanía Nuñez; Fernando García-Marqués; María Angeles Rodríguez-Hernández; Ana Cortés; Francisca Diaz; Acisclo Pérez-Martos; Carlos T Moraes; Patricio Fernández-Silva; Aleksandra Trifunovic; Plácido Navas; Jesús Vazquez; Jose A Enríquez
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

Review 3.  Mitochondrial mutations in cancer.

Authors:  M Brandon; P Baldi; D C Wallace
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

4.  Genome-scale CRISPR-Cas9 knockout screening in human cells.

Authors:  Ophir Shalem; Neville E Sanjana; Ella Hartenian; Xi Shi; David A Scott; Tarjei Mikkelson; Dirk Heckl; Benjamin L Ebert; David E Root; John G Doench; Feng Zhang
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

5.  Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNA.

Authors:  M P King; G Attardi
Journal:  Cell       Date:  1988-03-25       Impact factor: 41.582

6.  Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.

Authors:  Andrea Viale; Piergiorgio Pettazzoni; Costas A Lyssiotis; Haoqiang Ying; Nora Sánchez; Matteo Marchesini; Alessandro Carugo; Tessa Green; Sahil Seth; Virginia Giuliani; Maria Kost-Alimova; Florian Muller; Simona Colla; Luigi Nezi; Giannicola Genovese; Angela K Deem; Avnish Kapoor; Wantong Yao; Emanuela Brunetto; Ya'an Kang; Min Yuan; John M Asara; Y Alan Wang; Timothy P Heffernan; Alec C Kimmelman; Huamin Wang; Jason B Fleming; Lewis C Cantley; Ronald A DePinho; Giulio F Draetta
Journal:  Nature       Date:  2014-08-10       Impact factor: 49.962

Review 7.  Anticancer drugs targeting the mitochondrial electron transport chain.

Authors:  Jakub Rohlena; Lan-Feng Dong; Stephen J Ralph; Jiri Neuzil
Journal:  Antioxid Redox Signal       Date:  2011-09-01       Impact factor: 8.401

8.  Arrangement of electron transport chain components in bovine mitochondrial supercomplex I1III2IV1.

Authors:  Thorsten Althoff; Deryck J Mills; Jean-Luc Popot; Werner Kühlbrandt
Journal:  EMBO J       Date:  2011-09-09       Impact factor: 11.598

9.  Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker.

Authors:  Sheng Yin; Tsutomu Kabashima; Qinchang Zhu; Takayuki Shibata; Masaaki Kai
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

10.  Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis.

Authors:  Simone Cardaci; Liang Zheng; Gillian MacKay; Niels J F van den Broek; Elaine D MacKenzie; Colin Nixon; David Stevenson; Sergey Tumanov; Vinay Bulusu; Jurre J Kamphorst; Alexei Vazquez; Stewart Fleming; Francesca Schiavi; Gabriela Kalna; Karen Blyth; Douglas Strathdee; Eyal Gottlieb
Journal:  Nat Cell Biol       Date:  2015-08-24       Impact factor: 28.824

View more
  58 in total

Review 1.  Mitochondrial Metabolism as a Target for Cancer Therapy.

Authors:  Karthik Vasan; Marie Werner; Navdeep S Chandel
Journal:  Cell Metab       Date:  2020-07-14       Impact factor: 27.287

Review 2.  Mitohormesis, UPRmt, and the Complexity of Mitochondrial DNA Landscapes in Cancer.

Authors:  Timothy C Kenny; Maria L Gomez; Doris Germain
Journal:  Cancer Res       Date:  2019-09-04       Impact factor: 12.701

3.  Targeting pyrimidine metabolism for glioblastoma therapy.

Authors:  Veerakumar Balasubramaniyan; Krishna Bhat
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

4.  The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors.

Authors:  Christine R Cuthbertson; Hui Guo; Armita Kyani; Joseph T Madak; Zahra Arabzada; Nouri Neamati
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-23

5.  SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy.

Authors:  Zuzana Ezrova; Zuzana Nahacka; Jan Stursa; Lukas Werner; Erik Vlcak; Petra Kralova Viziova; Michael V Berridge; Radislav Sedlacek; Renata Zobalova; Jakub Rohlena; Stepana Boukalova; Jiri Neuzil
Journal:  Oncogene       Date:  2021-03-08       Impact factor: 9.867

Review 6.  Fumarate hydratase in cancer: A multifaceted tumour suppressor.

Authors:  Christina Schmidt; Marco Sciacovelli; Christian Frezza
Journal:  Semin Cell Dev Biol       Date:  2019-05-22       Impact factor: 7.727

7.  Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer.

Authors:  Meifang Yu; Nicholas D Nguyen; Yanqing Huang; Daniel Lin; Tara N Fujimoto; Jessica M Molkentine; Amit Deorukhkar; Ya'an Kang; F Anthony San Lucas; Conrad J Fernandes; Eugene J Koay; Sonal Gupta; Haoqiang Ying; Albert C Koong; Joseph M Herman; Jason B Fleming; Anirban Maitra; Cullen M Taniguchi
Journal:  JCI Insight       Date:  2019-07-23

8.  Persistence of the permeability transition pore in human mitochondria devoid of an assembled ATP synthase.

Authors:  Joe Carroll; Jiuya He; Shujing Ding; Ian M Fearnley; John E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

9.  Identification of DHODH as a therapeutic target in small cell lung cancer.

Authors:  Leanne Li; Sheng Rong Ng; Caterina I Colón; Benjamin J Drapkin; Peggy P Hsu; Zhaoqi Li; Christopher S Nabel; Caroline A Lewis; Rodrigo Romero; Kim L Mercer; Arjun Bhutkar; Sarah Phat; David T Myers; Mandar Deepak Muzumdar; Peter M K Westcott; Mary Clare Beytagh; Anna F Farago; Matthew G Vander Heiden; Nicholas J Dyson; Tyler Jacks
Journal:  Sci Transl Med       Date:  2019-11-06       Impact factor: 17.956

10.  Mitochondria as Target for Tumor Management of Hemangioendothelioma.

Authors:  Gayle M Gordillo; Ayan Biswas; Kanhaiya Singh; Abhishek Sen; Poornachander R Guda; Caroline Miller; Xueliang Pan; Savita Khanna; Enrique Cadenas; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2020-07-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.